(RGC) Regencell Bioscience - Performance 1038.5% in 12m
Compare RGC with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
22.95%
#24 in Group
Rel. Strength
99.96%
#4 in Universe
Total Return 12m
1038.52%
#2 in Group
Total Return 5y
471.43%
#5 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield 0.41%
(?) Percentile in Group
12m Total Return: RGC (1038.5%) vs XBI (-1.8%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
-1.68% | 29.3% | 171% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
| HLN NYSE Haleon |
-0.23% | 21% | 41.1% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
| AMGN NASDAQ Amgen |
-6.62% | 9.44% | 46.9% | 37 | 13.4 | 0.94 | -42.0% | -25.9% |
| LONN SW Lonza |
8.56% | 16.2% | 38.7% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
| BIM PA Biomerieux |
3.94% | 19.8% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
-2.63% | -21.7% | 8.36% | 32.4 | 21.5 | 0.27 | 64.4% | 51.8% |
| KMDA NASDAQ Kamada |
-2.12% | 27.5% | -10.6% | 26.6 | 24 | 0.96 | 80.4% | 43% |
| ERF PA Eurofins Scientific SE |
14% | -1.49% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
Performance Comparison: RGC vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RGC
| Total Return (including Dividends) | RGC | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 88.21% | 2.28% | -0.87% |
| 3 Months | 1478.95% | -10.48% | -7.58% |
| 12 Months | 1038.52% | -1.83% | 11.88% |
| 5 Years | 471.43% | -12.72% | 110.33% |
| Trend Score (consistency of price movement) | RGC | XBI | S&P 500 |
| 1 Month | 49.2% | 56.6% | 23% |
| 3 Months | 82.4% | -89.3% | -88.5% |
| 12 Months | 24.8% | -42.4% | 55.1% |
| 5 Years | -60.8% | -53.6% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #4 | 84.0% | 89.9% |
| 3 Month | #1 | 1,664% | 1,608% |
| 12 Month | #3 | 1,060% | 918% |
| 5 Years | #4 | 766% | 321% |
FAQs
Does RGC Regencell Bioscience outperforms the market?
Yes,
over the last 12 months RGC made 1038.52%, while its related Sector, the SPDR S&P Biotech (XBI) made -1.83%.
Over the last 3 months RGC made 1478.95%, while XBI made -10.48%.
Over the last 3 months RGC made 1478.95%, while XBI made -10.48%.
Performance Comparison RGC vs Indeces and Sectors
RGC vs. Indices RGC is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 93.2% | 89.1% | 811% | 1,027% |
| US NASDAQ 100 | QQQ | 92.2% | 86.8% | 811% | 1,026% |
| US Dow Jones Industrial 30 | DIA | 94.2% | 91.4% | 811% | 1,029% |
| German DAX 40 | DAX | 94.5% | 86.9% | 791% | 1,014% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 97.2% | 91.0% | 814% | 1,033% |
| Hongkong Hang Seng | HSI | 94.2% | 88.2% | 809% | 1,025% |
| India NIFTY 50 | INDA | 96.1% | 84.2% | 811% | 1,035% |
| Brasil Bovespa | EWZ | 94.0% | 83.6% | 807% | 1,044% |
RGC vs. Sectors RGC is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 93.0% | 89.3% | 805% | 1,015% |
| Consumer Discretionary | XLY | 93.1% | 88.3% | 808% | 1,025% |
| Consumer Staples | XLP | 96.7% | 88.0% | 806% | 1,027% |
| Energy | XLE | 97.7% | 102% | 817% | 1,050% |
| Financial | XLF | 94.6% | 90.3% | 803% | 1,016% |
| Health Care | XLV | 93.3% | 92.0% | 813% | 1,037% |
| Industrial | XLI | 92.8% | 88.1% | 810% | 1,029% |
| Materials | XLB | 93.8% | 90.6% | 818% | 1,042% |
| Real Estate | XLRE | 94.7% | 89.5% | 812% | 1,020% |
| Technology | XLK | 90.8% | 86.5% | 814% | 1,031% |
| Utilities | XLU | 96.1% | 88.2% | 809% | 1,017% |
| Aerospace & Defense | XAR | 92.3% | 81.8% | 797% | 1,012% |
| Biotech | XBI | 91.9% | 85.9% | 824% | 1,040% |
| Homebuilder | XHB | 93.9% | 90.5% | 826% | 1,046% |
| Retail | XRT | 94.8% | 88.8% | 817% | 1,041% |